70 related articles for article (PubMed ID: 7233487)
1. Pharmacokinetics and bioavailability of methylphenobarbital in man.
Hooper WD; Kunze HE; Eadie MJ
Ther Drug Monit; 1981; 3(1):39-44. PubMed ID: 7233487
[TBL] [Abstract][Full Text] [Related]
2. Qualitative and quantitative studies of methylphenobarbital metabolism in man.
Hooper WD; Kunze HE; Eadie MJ
Drug Metab Dispos; 1981; 9(4):381-5. PubMed ID: 6114839
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.
Lim WH; Hooper WD
Drug Metab Dispos; 1989; 17(2):212-7. PubMed ID: 2565213
[TBL] [Abstract][Full Text] [Related]
4. [Intoxication due to replacement of the precursor methylphenobarbital by phenobarbital].
Heeringa-Karreman M; van Munster ET
Ned Tijdschr Geneeskd; 2006 Apr; 150(17):977-9. PubMed ID: 17225740
[TBL] [Abstract][Full Text] [Related]
5. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
6. Preliminary observations on the pharmacokinetics of methylphenobarbitone.
Eadie MJ; Bochner F; Hooper WD; Tyrer JH
Clin Exp Neurol; 1978; 15():131-44. PubMed ID: 756009
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and pharmacokinetics of D-penicillamine.
Kukovetz WR; Beubler E; Kreuzig F; Moritz AJ; Nirnberger G; Werner-Breitenecker L
J Rheumatol; 1983 Feb; 10(1):90-4. PubMed ID: 6842492
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous assay of methylphenobarbital and phenobarbital in plasma using gas chromatography--mass spectrometry with selected ion monitoring.
Hooper WD; Kunze HE; Eadie MJ
J Chromatogr; 1981 May; 223(2):426-31. PubMed ID: 7251798
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
[TBL] [Abstract][Full Text] [Related]
14. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs.
Adebowale A; Du J; Liang Z; Leslie JL; Eddington ND
Biopharm Drug Dispos; 2002 Sep; 23(6):217-25. PubMed ID: 12214321
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
Abbo LA; Ko JC; Maxwell LK; Galinsky RE; Moody DE; Johnson BM; Fang WB
Vet Ther; 2008; 9(2):83-93. PubMed ID: 18597246
[TBL] [Abstract][Full Text] [Related]
16. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
Küpfer A; Branch RA
Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
[TBL] [Abstract][Full Text] [Related]
19. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma.
McNiel NO; Morgan LR
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of bemoradan, a long-acting inodilator in healthy males.
Huang SM; Brusser L; Chien SC; Simon D; Smith IL; Abrams LS; Lasseter K
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):62-4. PubMed ID: 8004360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
